INSULIN GLARGINE AND LIXISENATIDE

3660 reported adverse events

Drug classes: GLP-1 Receptor Agonist [EPC] Insulin Analog [EPC]

These side effects are most commonly reported by patients taking INSULIN GLARGINE AND LIXISENATIDE:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 467
1 PRODUCT STORAGE ERROR 402
2 OFF LABEL USE 355
3 ACCIDENTAL EXPOSURE TO PRODUCT 340
4 EXPOSURE VIA SKIN CONTACT 203
5 NAUSEA 154
6 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 149
7 VISUAL IMPAIRMENT 146
8 DRUG INEFFECTIVE 123
9 BLOOD GLUCOSE DECREASED 100
See all common reactions for INSULIN GLARGINE AND LIXISENATIDE

INSULIN GLARGINE AND LIXISENATIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE OPERATIONAL ISSUE 71 0.0165
1 PRODUCT STORAGE ISSUE 30 0.0079
2 EXPOSURE VIA SKIN CONTACT 203 0.0078
3 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 9 0.0075
4 EXPOSURE VIA EYE CONTACT 3 0.0071
5 PRODUCT DISPENSING ISSUE 30 0.0070
6 GLYCOSYLATED HAEMOGLOBIN DECREASED 9 0.0056
7 PRODUCT STORAGE ERROR 402 0.0046
8 BLOOD GLUCOSE ABNORMAL 71 0.0038
9 BLOOD GLUCOSE FLUCTUATION 40 0.0036
See all enriched reactions for INSULIN GLARGINE AND LIXISENATIDE